Literature DB >> 32234175

[Expert consensus on principal of clinical management of patients with severe emergent cardiovascular diseases during the epidemic period of COVID-19].

.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32234175     DOI： 10.3760/cma.j.cn112148-20200210-00066

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN： 0253-3758


× No keyword cloud information.
  5 in total

1.  Management strategies and outcomes of acute coronary syndrome (ACS) during Covid-19 pandemic.

Authors:  Mingliang Zuo; Shoubo Xiang; Sanjib Bhattacharyya; Qiuyi Chen; Jie Zeng; Chunmei Li; Yan Deng; Chungwah Siu; Lixue Yin
Journal:  BMC Cardiovasc Disord       Date:  2022-05-25       Impact factor: 2.174

Review 2.  Management and Treatment of COVID-19: The Chinese Experience.

Authors:  Fujun Peng; Lei Tu; Yongshi Yang; Peng Hu; Runsheng Wang; Qinyong Hu; Feng Cao; Taijiao Jiang; Jinlyu Sun; Guogang Xu; Christopher Chang
Journal:  Can J Cardiol       Date:  2020-04-17       Impact factor: 5.223

3.  Case Fatality Rate of COVID-19 and its Relationship to Sociodemographic Characteristics in Ecuador, 2020.

Authors:  Karla Margarita Flores Sacoto; Galo Antonio Sanchez Del Hierro; Felipe Gonzalo Moreno-Piedrahita Hernández; Jose Xavier Jarrin Estupiñan
Journal:  Int J Public Health       Date:  2022-09-06       Impact factor: 5.100

Review 4.  Rapid guide to the management of cardiac patients during the COVID-19 pandemic in Egypt: "a position statement of the Egyptian Society of Cardiology".

Authors:  Sameh Shaheen; Omar Awwad; Khalid Shokry; Magdy Abdel-Hamid; Adel El-Etriby; Hosam Hasan-Ali; Islam Shawky; Ahmad Magdy; Gamila Nasr; Hamza Kabil; Amr Elhadidy; Mohamad Zaki; Ahmad Hegab
Journal:  Egypt Heart J       Date:  2020-05-27

5.  The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic.

Authors:  Zhichao Xiao; Chang Xu; Daowen Wang; Hesong Zeng
Journal:  Catheter Cardiovasc Interv       Date:  2020-04-29       Impact factor: 2.585
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.